| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-08 |